Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DYNLL1 |
| Upstream (Parents) |
|---|
| (<<) ACTG1 → DYNLL1 |
| (<<) ALDOA → DYNLL1 |
| (<<) BDH1 → DYNLL1 |
| (<<) CYP1A2 → DYNLL1 |
| (<<) CYP4F2 → DYNLL1 |
| (<<) MAPK13 → DYNLL1 |
| (<<) PRSS3 → DYNLL1 |
| (<<) RAC1 → DYNLL1 |
| (<<) RDX → DYNLL1 |
| (<<) RPL35 → DYNLL1 |
| (<<) TMSB10 → DYNLL1 |
| (<<) TUBA1C → DYNLL1 |
| (<<) TUBB2C → DYNLL1 |
| Downstream (Children) |
|---|
| DYNLL1 → CPD (>>) |
| DYNLL1 → CSNK1E (>>) |
| DYNLL1 → CYP1A1 (>>) |
| DYNLL1 → GNAI2 (>>) |
| DYNLL1 → GPR153 (>>) |
| DYNLL1 → MTSS1 (>>) |
| DYNLL1 → RAF1 (>>) |
